Mesh.i
Curation
Ncbi
Racine
Curation
Checkpoint
Ncbi
Racine
Ncbi
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur le lymphœdème - Curation (Ncbi)

Index « Mesh.i » - entrée « Costs and Cost Analysis »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Cost-Benefit Analysis < Costs and Cost Analysis < Cote d'Ivoire  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000648 (????) B B Ganesh [Inde] ; A M Kader ; G S Agarwal ; M V Reddy ; B C HarinathA simple and inexpensive dot-blot assay, using a 66-kDa Brugia malayi microfilarial protein antigen, for diagnosis of bancroftian filarial infection in an endemic area.
000C77 (2002) D. De Anna [Italie] ; I. Corcos[Social relevance of venous lymphatic diseases].
001C14 (2004) Satoshi Omura [Japon] ; Andy CrumpThe life and times of ivermectin - a success story.
002932 (2007) B V Babu [Inde] ; S. Mishra ; S. Mishra ; B K SwainPersonal-protection measures against mosquitoes: a study of practices and costs in a district, in the Indian state of Orissa, where malaria and lymphatic filariasis are co-endemic.
002A08 (2007) Ann S. Goldman [États-Unis] ; Victoria H. Guisinger [États-Unis] ; Moses Aikins [Ghana] ; Maria Lourdes E. Amarillo ; Vicente Y. Belizario ; Bertha Garshong [Ghana] ; John Gyapong [Ghana] ; Conrad Kabali [Tanzanie] ; Hussein A. Kamal [Égypte] ; Sanjat Kanjilal [États-Unis] ; Dominique Kyelem [Burkina Faso] ; Jefrey Lizardo [République dominicaine] ; Mwele Malecela [Tanzanie] ; Godfrey Mubyazi [Tanzanie] ; P. Abdoulaye Nitièma [Burkina Faso] ; Reda M. R. Ramzy [Égypte] ; Thomas G. Streit [États-Unis] ; Aaron Wallace [États-Unis] ; Molly A. Brady [États-Unis] ; Richard Rheingans [États-Unis] ; Eric A. Ottesen [États-Unis] ; Anne C. Haddix [États-Unis]National Mass Drug Administration Costs for Lymphatic Filariasis Elimination
004111 (2011) K L Cooper ; Y. Meng ; S. Harnan ; S E Ward ; P. Fitzgerald ; D. Papaioannou ; L. Wyld ; C. Ingram ; I D Wilkinson ; E. LorenzPositron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation.
004496 (2012) B. Nandha [Inde] ; K. KrishnamoorthyImpact of education campaign on community-based vector control in hastening the process of elimination of lymphatic filariasis in Tamil Nadu, South India.
004790 (2011) Ann S. Goldman ; Molly A. Brady ; Abdel Direny ; Luccene Desir ; Roland Oscard ; Jean-Francois Vely ; Mary Linehan ; Margaret BakerCosts of Integrated Mass Drug Administration for Neglected Tropical Diseases in Haiti
005500 (2013) Wilma A. Stolk [Pays-Bas] ; Quirine A. Ten Bosch [Pays-Bas] ; Sake J. De Vlas [Pays-Bas] ; Peter U. Fischer [États-Unis] ; Gary J. Weil [États-Unis] ; Ann S. Goldman [États-Unis]Modeling the Impact and Costs of Semiannual Mass Drug Administration for Accelerated Elimination of Lymphatic Filariasis
007B43 (2016) Michelle C. Stanton [Royaume-Uni] ; Abigail Best [Royaume-Uni] ; Matthew Cliffe [Royaume-Uni] ; Louise Kelly-Hope [Royaume-Uni] ; Nana-Kwadwo Biritwum [Ghana] ; Linda Batsa [Ghana] ; Alex Debrah [Ghana]Situational analysis of lymphatic filariasis morbidity in Ahanta West District of Ghana.
008530 (2016) Hugo C. Turner [Royaume-Uni] ; Alison A. Bettis [Royaume-Uni] ; Brian K. Chu [États-Unis] ; Deborah A. Mcfarland [États-Unis] ; Pamela J. Hooper [États-Unis] ; Eric A. Ottesen [États-Unis] ; Mark H. Bradley [Royaume-Uni]The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000–2014)
009707 (1986) S P Sharma ; G J Kosare ; H. Biswas ; M. Das ; G K Trivedi ; G K SharmaControl of bancroftian filariasis in rural areas through selected treatment with diethylcarbamazine.
00B992 (1997) D. Reintgen [États-Unis] ; J. Albertini ; G. Milliotes ; J. Marshburn ; C W Cruse ; D. Rapaport ; C. Berman ; F. Glass ; N. Fensske ; A B Einstein ; G. LymanInvestment in new technology research can save future health care dollars.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i -k "Costs and Cost Analysis" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i  \
                -Sk "Costs and Cost Analysis" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Costs and Cost Analysis
}}
Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024